SOURCE: BIO-key International, Inc.

BIO-key International, Inc.

September 03, 2014 08:00 ET

BIO-key® Continues to Expand Footprint in the Healthcare Market

57 Eye Care Centers Now Using BIO-key to Access Patient Records

WALL, NJ--(Marketwired - Sep 3, 2014) - BIO-key International, Inc. (OTCQB: BKYI), a leader in fingerprint biometric identification technologies, cloud-based mobile credentialing and identity verification solutions, today reported the company added three additional eye care center customers, Eyecare Medical, Portland, ME, Hollingshead Eye Center, Boise, Idaho and I Care San Antonio in Texas. With the addition of these three new customers, BIO-key now provides fingerprint authentication solutions for 57 eye care centers throughout the U.S. BIO-key is delivering this capability through our partners Medflow and Davlong, both of which have a strong presence in the eye care market.

"Our customers recognized that entering a password each time they updated a patient record was cumbersome and negatively impacted their workflow," stated Jim Messier, Vice President Sales & Marketing, Medflow. "When we demonstrate how fast they can authenticate using BIO-key technology; most are eager to eliminate the use of passwords in favor of using their biometric."

The federal government has mandated the universal adoption of electronic health records for today's healthcare providers. The doctors, nurses and assistants affected are all benefiting from the streamlined and paperless electronic process. Yet, there is one area that offers opportunity for improvement: the authentication process. Healthcare professionals are required to remember and enter lengthy, sophisticated passwords, every time they update a patient record, as part of the authentication process. During a typical day, providers enter their password dozens of times, and in the hospital pharmacy we have seen this number reach as high as two hundred times. Passwords are extremely vulnerable to compromise and increase risk for the entire organization. When healthcare organizations replace cumbersome authentication methods, such as passwords, with BIO-key one touch fingerprint ID, they enhance security, improve workflow, reduce stress, meet compliance requirements and generate additional revenue by optimizing patient interactions.

"We believe the recent wins validate our investment in the healthcare market at all levels as we grow our sales through strategic partners to hospitals, clinics and physician practices. We recently added two new healthcare sales resources in support of our partners that have a significant presence in the EMR/EHR space," stated Mike DePasquale, BIO-key's Chairman and CEO. "Together with Medflow and Davlong we've developed a lengthy list of customers and testimonials; therefore the next step includes leveraging that success by making every potential prospect aware of the opportunity to improve their security and workflow."

BIO-key is an emerging leader in fingerprint authentication for healthcare institutions and medical practitioners as the company provides biometric authentication solutions for leading hospitals, clinics, private medical practices and blood centers. 

About BIO-key 
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (

BIO-key Safe Harbor Statement
Certain statements contained in this press release and in other public statements by the Company and Company officers include or may contain certain forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words "anticipate," "believe," "estimate," "will," "may," "future," "plan," "intend" and "expect" and similar expressions generally identify forward-looking statements. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Although we believe that our plans, intentions and expectations reflected in the forward-looking statements are reasonable, we cannot be sure that they will be achieved. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include: our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition between us and other companies in the biometric technology industry; market acceptance of biometric products generally and our products under development; delays in the development of products and statements of assumption underlying any of the foregoing, as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact Information

  • Investor & Media
    BIO-key International, Inc.
    Jay Meier
    Vice President Corporate Development
    Phone: 651-789-6116